AinB Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

AinB General Information

Description

Developer of AI-based antibody treatments designed for discovering and developing antibodies as therapeutics. The company's platform utilizes data-driven AI models to discover immuno-oncology antibodies, enabling health professionals to treat cancer-related diseases and supporting the development of new drugs for patients.

Contact Information

Website
www.ainbsci.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 204, Building B, Gwacheon Sangsang Xi Tower
  • 65, Gwacheon-daero 7-gil
  • Gwacheon, Gyeonggi
  • South Korea
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Room 204, Building B, Gwacheon Sangsang Xi Tower
  • 65, Gwacheon-daero 7-gil
  • Gwacheon, Gyeonggi
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AinB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 10-Jun-2026 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Early Stage VC 01-Jan-2024 Completed Startup
2. Accelerator/Incubator 10-Dec-2023 Completed Startup
1. Seed Round 09-Mar-2023 Completed Startup
To view AinB’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AinB Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AinB Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Celltrion Corporation
Digital Healthcare Partners Accelerator/Incubator Minority
Tech Incubator Program for Startup Accelerator/Incubator Minority
Medytox Venture Investment Corporate Venture Capital Minority
Yuhan Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

AinB FAQs

  • When was AinB founded?

    AinB was founded in 2022.

  • Where is AinB headquartered?

    AinB is headquartered in Gwacheon, South Korea.

  • What is the size of AinB?

    AinB has 10 total employees.

  • What industry is AinB in?

    AinB’s primary industry is Biotechnology.

  • Is AinB a private or public company?

    AinB is a Private company.

  • What is AinB’s current revenue?

    The current revenue for AinB is .

  • Who are AinB’s investors?

    Celltrion, Digital Healthcare Partners, Tech Incubator Program for Startup, Medytox Venture Investment, and Yuhan are 5 of 6 investors who have invested in AinB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process